1 . REFERENCE MATERIALS OF PHARMACEUTICAL SUBSTANCES: ABACAVIR STABLE MIXTURE SERIES NO: R066P0 FOR LABORATORY IN 1 5 MG VIAL
1 . REFERENCE MATERIALS OF PHARMACEUTICAL SUBSTANCES: ABACAVIR STABLE MIXTURE SERIES NO: R066P0 FOR LABORATORY IN 1 5 MG VIAL
10-March-2022
3006920000
1 . SAMPLE PLACEBO FOR ABACAVIR DOLUTEGAVIR AND LAMIVUDINE TABLETS 600/50/300 MG 1 0 G CONTAINER SERIES ADL-TI600/50/300
1 . SAMPLE PLACEBO FOR ABACAVIR DOLUTEGAVIR AND LAMIVUDINE TABLETS 600/50/300 MG 1 0 G CONTAINER SERIES ADL-TI600/50/300
24-January-2022
2942000000
1 . REFERENCE MATERIALS OF PHARMACEUTICAL SUBSTANCES: WORKING STANDARD OF ABACAVIR SULFATE SERIES NO. HLLI/ABWS/20/1 FOR LABORATORY TESTS IN A PACKAGE OF 789 MG
1 . REFERENCE MATERIALS OF PHARMACEUTICAL SUBSTANCES: WORKING STANDARD OF ABACAVIR SULFATE SERIES NO. HLLI/ABWS/20/1 FOR LABORATORY TESTS IN A PACKAGE OF 789 MG
03-February-2022
3004900002
1 . KIVEXA TAB 600MG/300MG 3X1 0_KZ/KILESA® (ABACAVIRA SULFATE (EQUIVALENT TO ABAKAVIR) 702 MG LAMIVUDINE 300 MG) TABLETS COVERED WITH 1 0 TABLETS IN CONTOUR CELL PACKAGING OR 1 0 TABLETS IN THE OPENING OF CHILDREN WITH A FINAL MEAL. PACKAGING. ON 3 CONTOUR PACKS IN A PACK FROM CARDBOARD. EXPIRY DATE 31 . 05.2024
1 . KIVEXA TAB 600MG/300MG 3X1 0_KZ/KILESA® (ABACAVIRA SULFATE (EQUIVALENT TO ABAKAVIR) 702 MG LAMIVUDINE 300 MG) TABLETS COVERED WITH 1 0 TABLETS IN CONTOUR CELL PACKAGING OR 1 0 TABLETS IN THE OPENING OF CHILDREN WITH A FINAL MEAL. PACKAGING. ON 3 CONTOUR PACKS IN A PACK FROM CARDBOARD. EXPIRY DATE 31 . 05.2024